JF has 25 years of experience performing PK, PK/PD and exposure-response analyses to support dosing rationale in various therapeutic areas.  Specialties include oncology, rare diseases and pediatric populations.  Over the last decade, he has provided pharmacometric analyses and strategic decisions that supported the regulatory approval of more than 25 small and large molecules.